Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma

Abstract Background Lung adenocarcinoma (LUAD) is a high-risk malignancy. Telomeres- (TRGs) and aging-related genes (ARGs) play an important role in cancer progression and prognosis. This study aimed to develop a novel prognostic model combined TRGs and ARGs signatures to predict the prognosis of pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhe Ye, Yiwei Huang, Tingting Chen, Youyi Wu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:https://doi.org/10.1186/s13019-024-03337-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544331330060288
author Zhe Ye
Yiwei Huang
Tingting Chen
Youyi Wu
author_facet Zhe Ye
Yiwei Huang
Tingting Chen
Youyi Wu
author_sort Zhe Ye
collection DOAJ
description Abstract Background Lung adenocarcinoma (LUAD) is a high-risk malignancy. Telomeres- (TRGs) and aging-related genes (ARGs) play an important role in cancer progression and prognosis. This study aimed to develop a novel prognostic model combined TRGs and ARGs signatures to predict the prognosis of patients with LUAD. Methods LUAD patient’s sample data and clinical data were obtained from public databases. The prognostic model was constructed and evaluated using the least absolute shrinkage and selection operator (LASSO), multivariate Cox analysis, time-dependent receiver operating characteristic (ROC), and Kaplan-Meier (K-M) analysis. Immune cell infiltration levels were assessed using single-sample gene set enrichment analysis (ssGSEA). Antitumor drugs with significant correlations between drug sensitivity and the expression of prognostic genes were identified using the CellMiner database. The distribution and expression levels of prognostic genes in immune cells were subsequently analyzed based on the TISCH database. Results This study identified eight characteristic genes that are significantly associated with LUAD prognosis and could serve as independent prognostic factors, with the low-risk group demonstrating a more favorable outcome. Additionally, a comprehensive nomogram was developed, showing a high degree of prognostic predictive value. The results from ssGSEA indicated that the low-risk group had higher immune cell infiltration. Ultimately, our findings revealed that the high-risk group exhibited heightened sensitivity to the Linsitinib, whereas the low-risk group demonstrated enhanced sensitivity to the OSI-027 drug. Conclusion The risk score exhibited robust prognostic capabilities, offering novel insights for assessing immunotherapy. This will provide a new direction to achieve personalized and precise treatment of LUAD in the future.
format Article
id doaj-art-fcbe83761c774fcba8162b320c48141c
institution Kabale University
issn 1749-8090
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj-art-fcbe83761c774fcba8162b320c48141c2025-01-12T12:39:02ZengBMCJournal of Cardiothoracic Surgery1749-80902025-01-0120111610.1186/s13019-024-03337-yComprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinomaZhe Ye0Yiwei Huang1Tingting Chen2Youyi Wu3Department of Oncology Radiotherapy, Ruian People’s Hospital, Wenzhou Medical UniversityDepartment of Oncology Radiotherapy, Ruian People’s Hospital, Wenzhou Medical UniversityDepartment of Oncology Radiotherapy, Ruian People’s Hospital, Wenzhou Medical UniversityDepartment of Oncology Radiotherapy, Ruian People’s Hospital, Wenzhou Medical UniversityAbstract Background Lung adenocarcinoma (LUAD) is a high-risk malignancy. Telomeres- (TRGs) and aging-related genes (ARGs) play an important role in cancer progression and prognosis. This study aimed to develop a novel prognostic model combined TRGs and ARGs signatures to predict the prognosis of patients with LUAD. Methods LUAD patient’s sample data and clinical data were obtained from public databases. The prognostic model was constructed and evaluated using the least absolute shrinkage and selection operator (LASSO), multivariate Cox analysis, time-dependent receiver operating characteristic (ROC), and Kaplan-Meier (K-M) analysis. Immune cell infiltration levels were assessed using single-sample gene set enrichment analysis (ssGSEA). Antitumor drugs with significant correlations between drug sensitivity and the expression of prognostic genes were identified using the CellMiner database. The distribution and expression levels of prognostic genes in immune cells were subsequently analyzed based on the TISCH database. Results This study identified eight characteristic genes that are significantly associated with LUAD prognosis and could serve as independent prognostic factors, with the low-risk group demonstrating a more favorable outcome. Additionally, a comprehensive nomogram was developed, showing a high degree of prognostic predictive value. The results from ssGSEA indicated that the low-risk group had higher immune cell infiltration. Ultimately, our findings revealed that the high-risk group exhibited heightened sensitivity to the Linsitinib, whereas the low-risk group demonstrated enhanced sensitivity to the OSI-027 drug. Conclusion The risk score exhibited robust prognostic capabilities, offering novel insights for assessing immunotherapy. This will provide a new direction to achieve personalized and precise treatment of LUAD in the future.https://doi.org/10.1186/s13019-024-03337-yTelomereAgingLung adenocarcinomaImmunotherapyPrognosis
spellingShingle Zhe Ye
Yiwei Huang
Tingting Chen
Youyi Wu
Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
Journal of Cardiothoracic Surgery
Telomere
Aging
Lung adenocarcinoma
Immunotherapy
Prognosis
title Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
title_full Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
title_fullStr Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
title_full_unstemmed Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
title_short Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
title_sort comprehensive analysis of telomere and aging related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
topic Telomere
Aging
Lung adenocarcinoma
Immunotherapy
Prognosis
url https://doi.org/10.1186/s13019-024-03337-y
work_keys_str_mv AT zheye comprehensiveanalysisoftelomereandagingrelatedsignatureforpredictingprognosisandimmunotherapyresponseinlungadenocarcinoma
AT yiweihuang comprehensiveanalysisoftelomereandagingrelatedsignatureforpredictingprognosisandimmunotherapyresponseinlungadenocarcinoma
AT tingtingchen comprehensiveanalysisoftelomereandagingrelatedsignatureforpredictingprognosisandimmunotherapyresponseinlungadenocarcinoma
AT youyiwu comprehensiveanalysisoftelomereandagingrelatedsignatureforpredictingprognosisandimmunotherapyresponseinlungadenocarcinoma